A Role for MAP Kinase Signaling in Behavioral Models of Depression and Antidepressant Treatment

Biological Psychiatry

Volumn 61, Issue 5, 2007, Pages 661-670

  Duman, Catharine H ^a   Schlesinger, Lee ^a   Kodama, Masafumi ^a   Russell, David S ^a   Duman, Ronald S ^a  

^a Departments of Psychiatry and Pharmacology   (United States)

Author keywords

BDNF; ERK; forced swim; learned helplessness; mouse; tail suspension

Indexed keywords

DESIPRAMINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; SERTRALINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; FORCED SWIMMING TEST; GENE DELETION; HETEROZYGOSITY; MALE; MOLECULAR MODEL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRESS; TAIL FLICK TEST;

ANALYSIS OF VARIANCE; ANILINE COMPOUNDS; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BENZAMIDES; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; HELPLESSNESS, LEARNED; HINDLIMB SUSPENSION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MOTOR ACTIVITY; SIGNAL TRANSDUCTION; SWIMMING;

EID: 33847308098     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.05.047     Document Type: Article

References (72)

1. Anisman H., and Matheson K. Stress, depression, and anhedonia: Caveats concerning animal models. Neurosci Biobehav Rev 2 (2005) 525-546
2. Atkins C., Selcher J.C., Petraitis J.J., Trzaskos J.M., and Sweatt J.D. The MAPK cascade is required for mammalian associative learning. Nat Neurosci 1 (1998) 602-609
3. Bai F., Li X., Clay M., Lindsrom T., and Skolnick P. Intra- and interstrain differences in models of "behavioral despair.". Pharmacol Biochem Behav 70 (2001) 187-192
4. Berton O., McClung C.A., Dileone R.J., Krishnan V., Renthal W., Russo S.J., et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311 (2006) 864-868
5. Borsch-Haubold A., Pasquet S., and Watson S.P. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059. SB also inhibits thromboxane synthase. J Biol Chem 273 (1998) 28766-28772
6. Bourin M., Chenu F., Ripoll N., and David D.J.P. A proposal of decision tree to screen putative antidepressants using forced swim and tail suspension tests. Behav Brain Res 164 (2005) 266-269
7. Cabib S., Ventura R., and Puglisis-Allegra S. Opposite imbalances between mesocortical and mesoaccumbens dopamine responses to stress by the same genotype depending on the living conditions. Behav Brain Res 129 (2002) 179-185
8. Caldarone B., Karthigeyan K., Harrist A., Hunsberger J.G., Wittmack E., King S.L., et al. Sex differences in response to oral amitriptyline in three animal models of depression in C57BL/6J mice. Psychopharm 170 (2003) 94-101
9. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301 (2003) 386-389
10. Chen B., Dowlatshahi D., MacQueen G.M., Wang J.-F., and Young L.T. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50 (2001) 260-265
11. Chida Y., Sudo N., and Kubo C. Social isolation stress exacerbates autoimmune disease in MRL/lpr mice. J Neuroimmunol 158 (2005) 138-144
12. Chourbaji S., Hellweg R., Brandis D., Zorner B., Zacher C., Lang U.E., et al. Mice with reduced bran-derived neurotrophic factor expression show decreased choline acetyltransferade activity, but regular brain monoamine levels and unaltered emotional behavior. Brain Res Mol Brain Res 121 (2004) 28-36
13. Conover J.C., Erickson J.T., Katz D.M., Bianchi L.M., Poueymirou W.T., McClain J., et al. Neuronal deficits, not involving motor neurons, in mice lacking BDNF and/or NT4. Nature 375 (1995) 235-238
14. Conti A., Cryan J.F., Dalvi A., Lucki L., and Blendy J.A. CREB is essential for the upregulation of BDNF transcription, but not the behavioral or endocrine responses to antidepressant drugs. J Neurosci 22 (2002) 3262-3268
15. Cryan J.F., Markou A., and Lucki I. Assessing antidepressant activity in rodents: Recent developments and future needs. Trends Pharmacol Sci 23 (2002) 238-245
16. David D., Renard C.E., Jolliet P., Hascoet M., and Bourin M. Antidepressant-like effects in various mice strains in the forced swimming test. Psychopharmacology 166 (2003) 373-382
17. Davies S., Reddy H., Caivano M., and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351 (2000) 95-105
18. Duman R., Heninger G.R., and Nestler E.J. A molecular and cellular theory of depression. Arch Gen Psychiatry 54 (1997) 597-606
19. Duman R.S., and Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol Psychiatry (2006) April 19 [Epub ahead of print].
20. Dwivedi Y., Rizavi H.S., Conley R.R., Tamminga C.A., and Pandey G.N. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 60 (2003) 804-815
21. Dwivedi Y., Rizavi H.S., Roberts R.C., Conley R.C., Tamminga C.A., and Pandey G.N. Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J Neurochem 77 (2001) 916-928
22. Einat H., Yuan P., Gould T.D., Li J., Du J., Zhang L., Manji H.K., and Chen G. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci 23 (2003) 7311-7316
23. Eisch A.J., Bolanos C.A., de Wit J., Simonak R.D., Pudiak C.M., Barrot M., et al. Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: A role in depression. Biol Psychiatry 54 (2003) 994-1005
24. Enfors P., Lee K.-F., and Jaenisch R. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 368 (1994) 147-150
25. Fumagalli F., Molteni R., Calabrese F., Frasca A., Racagni G., and Riva M.A. Chronic fluoxetine administration inhibits extracellular signal-regulated kinase 1/2 phosphorylation in rat brain. J Neurosci 93 (2005) 1551-1560
26. Gerdjikov T., Ross G.M., and Beninger R.J. Place preference induced by nucleus accumbens amphetamine is impaired by antagonists of ERK or p38 MAP kinases in rats. Behav Neurosci 118 (2004) 740-750
27. Gorski J., Balogh S.A., Wehner J.M., and Jones K.R. Learning deficits in forebrain-restricted brain derived neurotrophic factor mutant mice. Neuroscience 121 (2003) 341-354
28. Guidotti A., Dong E., Matsumoto K., Pinna G., Rasmusson A.M., and Costa E. The socially-isolated mouse: a model to study the putative role of allopregnanolone and 5alpha-dihydroprogesterone in psychiatric disorders. Brain Res Brain Res Rev 37 (2001) 110-115
29. Henderson C. Role of neurotrophic factors in neuronal development. Curr Opin Neurobiol 6 (1996) 64-70
30. Henn F., and Vollmayr B. Stress models of depression: forming genetically vulnerable strains. Neurosci Biobehav Rev 29 (2005) 799-804
31. Holmes A., Yang R.J., Murphy D.L., and Crawley J.N. Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology 27 (2002) 914-923
32. Huang E., and Reichardt L.F. Trk receptors: Roles in neuronal signal transduction. Annu Rev Biochem 72 (2003) 609-642
33. Karege F., Perret H., Bondolfi G., Schwald M., Bertschy G., and Aubrey J.M. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 109 (2002) 143-148
34. Kaufman J., Yang B.Z., Douglas-Palumberi H., Grasso D., Lipschitz D., Houshyar S., et al. Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry 59 (2006) 673-680
35. Kelly A., Laroche S., and Davis S. Activation of mitogen-activated protein kinase/extracellular signal-regulated kinase in hippocampal circuitry is required for consolidation and reconsoligation of recognition memory. J Neurosci 23 (2003) 5354-5360
36. Kendler K., Karkowski L.M., and Prescott C.A. Causal relationship between stressful life events and the onset of major depression. Am J Psychiatry 156 (1999) 837-841
37. Kessler R. The effects of stressful life events on depression. Ann Rev Psychol 48 (1997) 191-214
38. Kodama M., Russell D.S., and Duman R.S. Electroconvulsive seizures increase the expression of MAP kinase phosphatases in limbic regions of rat brain. Neuropsychopharmacology 30 2 (2005) 360-371
39. Korte M., Carroll P., Wolf E., Brem G., Thoenen H., and Bonhoeffer T. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc Natl Acad Sci U S A 92 (1995) 8856-8860
40. Levinson D. The genetics of depression: A review. Biol Psychiatry (2005) November 18 [EPub ahead of print].
41. Lucki I., Dalvi A., and Mayorga A.J. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology 155 (2001) 315-322
42. Lyons W., Mamounas L.A., Ricaurte G.A., Coppola V., Reid S.W., Bora S.H., et al. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci U S A 96 (1999) 15239-15244
43. MacQueen G., Ramakrishnan K., Croll S.D., Siuciak J.A., Yu G., Young L.T., and Fahnestock M. Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression. Behav Neurosci 5 (2001) 1145-1153
44. Maier S., and Seligman M.E.P. Learned helplessness: Theory and evidence. J Exp Psychol 105 (1976) 3-46
45. Manji H., Drevets W.C., and Charney D.S. The cellular neurobiology of depression. Nat Med 7 (2001) 541-547
46. Meller E., Shen C., Nikolao T.A., Jensen C., Tsimberg Y., Chen J., and Gruen R.J. Region-specific effects of acute and repeated restraint stress on the phosphorylation of mitogen-activated protein kinase. Brain Res 979 (2003) 57-64
47. Monteggia L., Barrot M., Powell C.M., Berton O., Galanis V., Gemelli T., et al. Essential role of brain-derived neuroprophic factor in adult hippocampal function. Proc Natl Acad Sci U S A 101 (2004) 10827-10832
48. Nestler E., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., and Monteggia L.M. Neurobiology of depression. Neuron 34 (2002) 13-25
49. Nibuya M., Morinobu S., and Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15 (1995) 7539-7547
50. Ohno M., Frankland P.W., Chen A.P., Costa R.M., and Silva A.J. Inducible, pharmacogenetic approaches to the study of learning and memory. Nat Neurosci 4 (2001) 1238-1243
51. Pereira D., Carvalho A.P., and Duarte C.B. Non-specific effects of the MEK inhibitors PD098,059 and U0126 on glutamate release from hippocampal synaptosomes. Neuropharmacology 42 (2002) 9-19
52. Ribeiro M., Schofield M.G., Kemenes I., O'Shea M., Kemenes G., and Benjamin P.R. Activation of MAPK is necessary for long-term memory consolidation following food-reward conditioning. Learn Mem 12 (2005) 538-545
53. Rios M., Fan G., Fekete C., Kelly J., Bates B., Kuehn R., et al. Conditioned deletion of brain-derived neurotrophic factor in the post-natal brain leads to obesity and hyperactivity. Mol Endocrinol 15 (2001) 1748-1757
54. Russo-Neustadt A., Beard R.C., Huang Y.M., and Cotman C.W. Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus. Neuroscience 101 (2000) 305-312
55. Russo-Neustadt A., Ha T., Ramirez R., and Kesslak J.P. Physical activity-antidepressant treatment combination: Impact on brain-derived neurotrophic factor and behavior in an animal model. Behav Brain Res 120 (2001) 87-95
56. Saarelainen T., Hendolin P., Lucas G., Koponen E., Sairanen M., MacDonald E., et al. Activation of the trkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci 23 (2003) 349-357
57. Sasaguri K., Kikuchi M., Hori N., Yuyama N., Onozuka M., and Sato S. Suppression of stress immobilization-induced phosphorylation of ERK 1/2 by biting in the rat hypothalamic paraventricular nucleus. Neurosci Lett 383 (2005) 160-164
58. Schuman E. Neurotrophin regulation of synaptic transmission. Curr Opin Neurobiol 9 (1999) 105-109
59. Shanks N., and Anisman H. Strain-specific effects of antidepressants on escape deficits induced by inescapable shock. Psychopharmacology 99 (1989) 122-128
60. Sharma S., Bagnall M.W., Sutton M.A., and Carew T.J. Inhibition of calcineurin facilitates he induction of memory for sensitization in Aplysia: Requirement of mitogen-activated protein kinase. Proc Natl Acad Sci U S A 100 (2003) 4861-4866
61. Shen C.P., Tsimberg Y., Salvadore C., and Meller E. Activation of Erk and JNK MAPK pathways by acute swim stress in rat brain regions. BMC Neurosci 5 (2004) 36.
62. Shirayama Y., Chen A.C.-H., Nakagawa S., Russell R.S., and Duman R.S. Brain derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22 (2002) 3251-3261
63. Siuciak J.A., Lewis D.R., Wiegand S.J., and Lindsay R. Antidepressant-like effect of brain derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 56 (1997) 131-137
64. Smith M.A., Makino S., Kvetnansky R., and Post R.M. Stress alters the express of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 15 (1995) 1768-1777
65. Spani D., Arras M., Konig B., and Rulicke T. Higher heart rate of laboratory mice housed individually vs in pairs. Lab Anim 37 (2003) 57-64
66. Steru L., Chermat R., Thierry B., and Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85 3 (1985) 367-370
67. Sweatt J. The neuronal MAP kinase cascade: A biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem 76 (2001) 1-10
68. Thoenen H. Neurotrophins and neuronal plasticity. Science 270 (1995) 593-598
69. Tiraboschi E., Tardito D., Kasahara J., Moraschi S., Pruneri P., Gennarelli M., et al. Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades. Neuropsychopharmacology 29 (2004) 1831-1840
70. Trentani A., Kuipers S.D., Ter Horst G.J., and Den Boer J.A. Selective chronic stress-induced in vivo ERK1/2 hyperphosphorylation in medial prefrontocortical dendrites: Implications for stress-related cortical pathology?. Eur J Neurosci 15 (2002) 1681-1691
71. Tucker K., Meyer M., and Barde Y.A. Neurotrophins are required for nerve growth during development. Nat Neurosci 4 (2001) 29-37
72. Yung H., Wyttenbach A., and Tolkovsky A.M. Aggravation of necrotic death of glucose-deprived cells by the MEK1 inhibitors U0126 and PD18461 through depletion of ATP. Biochem Pharmacol 68 (2004) 351-360